Quote:

---

there is zero chance Leronlimab has not been continued in the surviving patients in this trial.

---

Cytodyn may be using either the primary completion date or the study completion date as last date of dosing. Best case scenario - basket trial - March, 2022, mTNBC - September, 2022, compassionate use being a study rather than a trial does not have an end date but they had announced at some point they were shutting it down.